Rapamycin Sirolimus RAPA CAS 53123-88-9 Assay ≥98.5% API Factory High Purity

Inkcazelo emfutshane:

Igama leKhemikhali: Rapamycin;iSirolimus;I-RAPA

CAS: 53123-88-9

Imbonakalo: Umgubo weCrystalline oMhlophe okanye oMhlophe

Uvavanyo: ≥98.5%

Macrolide Immunosuppressive Agent

Umgangatho ophezulu we-API, iMveliso yoRhwebo

E-mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Umenzi onobunyulu obuPhezulu kunye noMgangatho oZinzile
Igama leKhemikhali: Rapamycin;iSirolimus;I-RAPA
CAS: 53123-88-9
Macrolide Immunosuppressive Agent
Umgangatho ophezulu we-API, iMveliso yoRhwebo

Iipropati zeMichiza:

Igama leMchiza	I-Rapamycin
Izithethantonye	iSirolimus;I-RAPA;AY-22989
Inombolo yeCAS	53123-88-9
Inombolo yeCAT	RF-API59
Ubume beStokhwe	Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram
Ifomula yeemolekyuli	C51H79NO13
Ubunzima beMolekyuli	914.19
Indawo yokunyibilika	183.0 ~ 185.0℃
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo weCrystalline oMhlophe okanye oMhlophe
Isazisi A	Uluhlu lwe-IR ye-potassium bromide yokulungiswa kwesampulu ibonisa ubuninzi kumaza obude obufanayo naleyo yolungiselelo olufanayo lomgangatho wereferensi yangaphakathi.
Isazisi B	I-UV spectrum ye-95% yokulungiswa kwe-ethanol yesampulu ibonisa ubukhulu be-267nm, 277nm, 288nm njengaleyo yolungiselelo olufanayo lomgangatho wereferensi yangaphakathi.
Isazisi C	Ixesha lokugcinwa kweencopho ze-trans-kunye ne-cis-stereoisomers kwichromatogram yolungiselelo lovavanyo lihambelana nekhromatogram yolungiselelo oluqhelekileyo, njengoko lufunyenwe kuvavanyo.
Ukujikeleziswa kwe-Optical	-147.0 ° ~ -157.0 °
Ilahleko ekomisweni	≤0.50%
Intsalela kwi-Ignition	≤0.20%
Iintsimbi ezinzima	≤20ppm
Ukungacoceki komntu	≤1.5%
Ukungcola ngokupheleleyo	≤2.0% (ngaphandle kweCis-Stereoisomer yeSirolimus)
Cis-Stereoisomer of Sirolimus	≤5.0%
Izinyibilikisi ezishiyekileyo
I-Ethanol	≤5000ppm
I-Ethyl Acetate	≤5000ppm
Cyclohexane	≤5000ppm
I-acetone	≤5000ppm
I-Diethyl Ether	≤5000ppm
Isivavanyi	≥98.5% (Ibalwe i-trans- kunye ne-cis-stereoisomer ye-sirolimus ngokwe-dired basis)
Umgangatho woVavanyo	I-Pharmacopoeia yaseTshayina (CP);Umgangatho woShishino
Ukusetyenziswa	I-Active Pharmaceutical ingredient (API)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Rapamycin (i-Sirolimus; i-AY 22989) yi-activator ye-autophagy, uhlobo olutsha lwe-macrolide immunosuppressive agent eneziphumo ezilungileyo zokunyanga, ubuthi obuphantsi, kwaye akukho nephrotoxicity.Ingasetyenziselwa ukugcina i-immunity yamalungu okutshintshwa (ingakumbi kukutshintshwa kwezintso) ukunciphisa ukulahlwa kwe-immunological emva kotyando lokutshintshwa kwelungu.